More case studies
How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market
Rescuing a Global Biotech's Oncology Study with Cetuximab
How CSI used its scientific expertise at the protocol stage to provide flexibility in sourcing strategy and ensure high volumes of a single product were supplied on time to multiple countries
Delivering Comparators for a Global Allergy Study
How CSI’s regulatory guidance and robust sourcing solutions ensured the success of a global flu vaccine trial that could not afford to run behind schedule
Sourcing Flu Vaccines for a Global Trial
CSI was tasked with providing crucial support to a large biotechnology company in distributing medical devices for a three-year study spanning 15 countries in Europe (EU), the United States (US) and Asia-Pacific (APAC). A central sourcing approach was not suitable for the client due to import and export complications, as well as the high VAT of the required product.
It was a particular challenge to find 15 warehouses that were able to accommodate the storage of the required medical devices within a short timeframe since they contained lithium batteries, which are classed as dangerous goods. The majority of GMP warehouses are limited to the storage of medication, which made qualification all the more complex.
After conducting a rigorous search and leveraging our networks, CSI identified suitable partner warehouses, auditing and qualifying them within the rapid timeframe required for the client’s study to progress without delay.
With CSI’s outstanding supply chain solutions and expertise in import and export, we provided stock to all depots and sites across the world. We also managed the return of all devices, creating country-specific return kits for each location. CSI’s flexible approach to ancillary sourcing ensured we were able to supply all sites before the Site Initiation Visit (SIV), enabling the client’s study to commence on time.
Global Medical Device Distribution
How CSI’s flexible approach to global distribution ensured a large biotech’s three-year study across 15 countries could proceed without delay
To distribute medical devices containing lithium batteries for a large biotech’s three-year study spanning 15 countries around the world
CSI audited and qualified 15 new warehouses able to accommodate the devices (classed as dangerous goods) within a tight timeframe
Stock was provided to all sites globally, the client’s study commenced without delay, and CSI managed all returns with country-specific kits
Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements